Home/Hedge Fund Intelligence/Ultragenyx Pharmaceutical Inc.
Nasdaq: RAREStockForm 13F30 Jun 2026

Hedge funds that hold Ultragenyx Pharmaceutical Inc. Nasdaq: RARE

CUSIP 90400D108 · who reports it, how much, and how much it matters to them

35 of the 720 hedge fund managers we track reported shares of Ultragenyx Pharmaceutical Inc. (Nasdaq: RARE) on Form 13F for 30 June 2026. Between them they reported USD 801m. The largest position belongs to RTW Investments, at USD 260m. The manager with the most riding on it is Eagle Health Investments, where it is 4.9% of the reported book.

Managers reporting it35of 720 we track
Value they reportUSD 801mshares only, 30 Jun 2026
Funds they run560with a file on PPLI.com
Largest positionUSD 260mRTW Investments
Typical weight0.0%median share of a manager's book
Heaviest weight4.9%Eagle Health Investments

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

35 managers, USD 801m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Ultragenyx Pharmaceutical Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1RTW Investments2 funds on PPLI.comUSD 260m2.2%
2Two Sigma Investments35 funds on PPLI.comUSD 121m0.1%
3D. E. Shaw & Co.15 funds on PPLI.comUSD 58m0.0%
4Sofinnova Investments1 fund on PPLI.comUSD 57m3.0%
5Adage Capital Management1 fund on PPLI.comUSD 53m0.1%
6Voloridge Investment Management6 funds on PPLI.comUSD 41m0.2%
7Rock Springs Capital Management2 funds on PPLI.comUSD 32m1.6%
8Eagle Health Investments1 fund on PPLI.comUSD 30m4.9%
9Millennium Management6 funds on PPLI.comUSD 25m0.0%
10Palo Alto Investors6 funds on PPLI.comUSD 20m2.8%
11Sphera Funds Management1 fund on PPLI.comUSD 20m2.6%
12Renaissance Technologies13 funds on PPLI.comUSD 14m0.0%
13Squarepoint Ops7 funds on PPLI.comUSD 11m0.0%
14Walleye Capital8 funds on PPLI.comUSD 11m0.0%
15Citadel Advisors32 funds on PPLI.comUSD 7m0.0%
16Atom Investors1 fund on PPLI.comUSD 5.7m0.5%
17Marshall Wace LLP84 funds on PPLI.comUSD 5.3m0.0%
18Boothbay Fund Management2 funds on PPLI.comUSD 5.2m0.1%
19Eversept Partners3 funds on PPLI.comUSD 5.1m0.3%
20Moore Capital Management7 funds on PPLI.comUSD 4.3m0.1%
21Brevan Howard Capital Management39 funds on PPLI.comUSD 3.4m0.0%
22Schonfeld Strategic Advisors30 funds on PPLI.comUSD 1.8m0.0%
23Engineers Gate Manager1 fund on PPLI.comUSD 1.6m0.0%
24Dafna Capital Management6 funds on PPLI.comUSD 1.6m0.3%
25Jain Global1 fund on PPLI.comUSD 1.4m0.0%
26Capital Fund Management S.A.12 funds on PPLI.comUSD 1.1m0.0%
27Entrypoint Capital1 fund on PPLI.comUSD 860,0000.2%
28The Quarry1 fund on PPLI.comUSD 835,0000.1%
29Lighthouse Investment Partners190 funds on PPLI.comUSD 694,0000.0%
30Aquatic Capital Management3 funds on PPLI.comUSD 560,0000.0%
31Capstone Investment Advisors25 funds on PPLI.comUSD 549,0000.0%
32Landscape Capital Management4 funds on PPLI.comUSD 223,0000.0%
33Verdad Advisers6 funds on PPLI.comUSD 208,0000.2%
34Freestone Grove Partners1 fund on PPLI.comUSD 62,1390.0%
35Fulcrum Asset Management LLP7 funds on PPLI.comUSD 3,4360.0%
Next: where it matters most
Where it matters most

For Eagle Health Investments it is 4.9% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Eagle Health InvestmentsUSD 30m4.9%
2Sofinnova InvestmentsUSD 57m3.0%
3Palo Alto InvestorsUSD 20m2.8%
4Sphera Funds ManagementUSD 20m2.6%
5RTW InvestmentsUSD 260m2.2%
6Rock Springs Capital ManagementUSD 32m1.6%
7Atom InvestorsUSD 5.7m0.5%
8Dafna Capital ManagementUSD 1.6m0.3%
9Eversept PartnersUSD 5.1m0.3%
10Entrypoint CapitalUSD 860,0000.2%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Ultragenyx Pharmaceutical Inc.

What is the ticker symbol of Ultragenyx Pharmaceutical Inc.?

Ultragenyx Pharmaceutical Inc. trades under the symbol RARE on the Nasdaq. Its CUSIP, the code used on Form 13F, is 90400D108.

Which hedge funds own Ultragenyx Pharmaceutical Inc. (Nasdaq: RARE)?

35 of the 720 hedge fund managers PPLI.com tracks reported Ultragenyx Pharmaceutical Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by RTW Investments (USD 260m), Two Sigma Investments (USD 121m), D. E. Shaw & Co. (USD 58m), Sofinnova Investments (USD 57m) and Adage Capital Management (USD 53m).

How many hedge funds hold Ultragenyx Pharmaceutical Inc.?

35 managers in our coverage reported it, and between them they run 560 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Ultragenyx Pharmaceutical Inc.?

Eagle Health Investments, where the position was 4.9% of the reported 13F book at 30 June 2026.

Does this show who is short Ultragenyx Pharmaceutical Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Ultragenyx Pharmaceutical Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.